<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01270048</url>
  </required_header>
  <id_info>
    <org_study_id>B070057</org_study_id>
    <nct_id>NCT01270048</nct_id>
  </id_info>
  <brief_title>The Effect of Bunsimgieum on the Chest Discomfort of Hwa-byung's Major Symptom</brief_title>
  <official_title>The Effect of Bunsimgi-eum(Fenxinqiyin) on the Chest Discomfort of Hwa-byung's Major Symptom : Randomized, Double-blinded, Placebo-control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea Health Industry Development Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea Health Industry Development Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to examine the effect of Bunsimgi-eum on the chest discomfort
      of Hwa-byung's major symptom and develope and establish pattern identification system in
      Hwa-byung.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">144</enrollment>
  <condition>Hwa-byung (Disorder)</condition>
  <arm_group>
    <arm_group_label>Bunsimgieum extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>name of product: 'mild-x-gwarip'
standard code for item: 200005689
shape, type: extract(brown)
usage, content: adults;three times a day, each taken before or between meals
dose, standard: 2.5g for each sack, capsulated
storage : airtight container, stored in room temperature
expiration date : 36months after manufacture
macufacturing company: KyungBangnShinYak inc.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo; corn flour,</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>raw material: total contents(500㎎); cornstarch 50.0%(250.0㎎), 당수화물 49.45%(247.25㎎), caramel pigment 0.5%(2.5㎎), SsangHwa fragrance 0.05%(0.25㎎)
shape, type: extract(brown)
usage, dose: adults: three times a day, 1 sack before or between meals
dose, standard: 2.5g for each sack, capsulated
storage : airtight container, stored in room temperature
expiration date : 36 months after manufacture
manufacturing company: KyungBangnShinYak inc.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>mild-ex-gwarip</intervention_name>
    <description>three times a day, AC 30 min., 4 capsules taken each time (4capsules=2.5g), 8 weeks.</description>
    <arm_group_label>Bunsimgieum extract</arm_group_label>
    <other_name>standard code for item: 200005689</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>three times a day, AC 30 min., 4 capsules taken each time (4capsules=2.5g), 8 weeks.</description>
    <arm_group_label>Placebo; corn flour,</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female aged 20-65

          -  subjects who meet structured interview criteria for Hwa-Byung Diagnosis

        Exclusion Criteria:

          -  duration of illness less than 6 months

          -  current or past history of delusions, hallucination

          -  past history of at least one manic episode, hypomanic episode, or mixed episode

          -  current or past history of alcohol abuse or alcohol dependence history

          -  taking substances(e.g. steroids) which might affect symptoms

          -  medical conditions(e.g. hyperthyroidism, hypothyroidism, heart disease) that might
             affect symptoms

          -  current with hepatoma, hepatic cirrhosis, chronic renal failure, congestive heart
             failure

          -  pregnancy, lactation, women not using medically accepted means of birth control

          -  considered not apt to carry out clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>In-Chul Jung, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oriental Hospital of Daejon University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oriental Hospital of Daejon University</name>
      <address>
        <city>Daejon</city>
        <state>Choong-Chung-Do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2011</study_first_submitted>
  <study_first_submitted_qc>January 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2011</study_first_posted>
  <last_update_submitted>January 4, 2011</last_update_submitted>
  <last_update_submitted_qc>January 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2011</last_update_posted>
  <responsible_party>
    <name_title>Sun-Tae. Kim</name_title>
    <organization>Korea Health Industry Development Institute</organization>
  </responsible_party>
  <keyword>Hwa-byung, Bunsimgi-eum(Fenxinqiyin)</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

